medigraphic.com
ISSN 1817-5996 (Electronic)

2013, Number 3

<< Back Next >>

Rev Cub de Reu 2013; 15 (3)

Transverse myelitis as premiere of a systemic lupus erythematous

Gil AR, Solis CU, Milera RJ, de Armas HA

Language: Spanish
References: 10
Page: 209-213
PDF size: 263.02 Kb.


ABSTRACT

The systemic lupus erythematous is illness autoimmunity, systemic, characterized by the autoanticuerpos production and a diversity of clinical manifestations among those that highlight the neuropsychiatric manifestations. Among these flames powerfully the attention the transverse myelitis which is an inflammatory process that affects a restricted area of the spinal cord. The presentation, usually dramatic, with a quick progression of the symptoms that you/they involve the functions motorboats, sensitive and autonomous, makes of these a medical emergency. The association between transverse myelitis and illnesses rheumatic autoimmunity has been reported; however, in some cases it continues being a strange combination.


REFERENCES

  1. Alarcón Segovia D. Tratado hispanoamericano de Reumatología, volumen II, Bogota: Ed. Nomos S.A; 2006. p. 755-69.

  2. Cagnoli C, Sundgren L, Kairys A, Graft C, Clauw D, Gebarski S, McCune J, Schmidt-Wilcke T. Changes in regional brain morphology in neuropsychiatric systemic lupus erythematosus. Journal of Rheumatology. [revista en Internet]. 2012 [citado 2013 sep 25];39(5):959-67. Disponible en: http://www.jrheum.org/content/39/5/959.short

  3. Schulz W, Shenin M, Mehta A, Kebede A, Fluerant M. Initial presentation of acute transverse myelitis in systemic lupus erythematosus: Demographics, diagnosis, management and comparison to idiopathic cases. Rheumatol Int. 2012;32(9):2623-78.

  4. Kerr A, Ayetey H. Immunopathogenesis of acute transverse myelitis. Curr Opin Neurol 2002;15(3):339-47.

  5. Alarcón Segovia D, Deleze M, Oria CV. Antiphospholipid antibodies and the phospholipid syndrome in systemic lupus erythematosus. A prospective analisis of 500 patients. Medicine. 1989;68(6):353-65.

  6. Hermosillo-Romo D, Brey LR. Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus NPSLE. Best Pract Res Clin Rheumatol. 2002:16(2):229-44.

  7. Aguilera G, Abud C. Manifestaciones neuropsiquiátricas en lupus eritematoso generalizado: bases fisiopatogénicas y terapéuticas. Reumatol Clin. [revista en Internet]. 2013 [citado 2013 sep 25];9(6):331-3. Disponible en: http://www.reumatologiaclinica.org/es/pdf/90250955/S300/

  8. Sibbitt L, Brooks M, Kornfeld M, Hart L, Bankhurst D, Roldan A. Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum.[revista en Internet]. 2010 [citado 2013 sep 25];40(1):32-52. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586567/

  9. Luyendijk J, Steens C, Ouwendijk J, Steup M, Bollen L, Van derGrond J. Neuropsychiatric systemic lupus erythematosus; lessons learned from magnetic resonance imaging. Arthritis Rheum. 2011;63(3):722-32.

  10. Tristano G. Mielitis Transversa asociada a enfermedades autoinmunes. Revisión. Invest. Clín. 2009:50(2):251-70.




2020     |     www.medigraphic.com